Bone,
Journal Year:
2019,
Volume and Issue:
131, P. 115160 - 115160
Published: Nov. 20, 2019
Studies
have
shown
that
osteoporosis
and
atherosclerosis
are
comorbid
conditions
sharing
common
risk
factors
pathophysiological
mechanisms.
Understanding
these
is
crucial
in
order
to
develop
shared
methods
for
stratification,
prevention,
diagnosis
treatment.
The
aim
of
this
study
was
apply
a
system-level
bioinformatics
approach
lipidome-wide
data
pinpoint
the
lipidomic
architecture
jointly
associated
with
surrogate
markers
complex
diseases.
based
on
Cardiovascular
Risk
Young
Finns
Study
cohort
from
2007
follow-up
(n
=
1494,
aged
30–45
years,
women:
57%).
Liquid
chromatography-tandem
mass
spectrometry
(LC-MS/MS)
used
analyse
serum
lipidome,
involving
437
molecular
lipid
species.
subclinical
osteoporotic
included
indices
bone
mineral
density
content,
measured
using
peripheral
quantitative
computer
tomography
distal
shaft
sites
both
tibia
radius.
atherosclerotic
carotid
bulbus
intima
media
thickness
high-resolution
ultrasound.
Weighted
co-expression
network
analysis
performed
identify
networks
densely
interconnected
species
(i.e.
modules)
atherosclerosis.
levels
(lipid
profiles)
each
modules
were
summarized
by
first
principal
component
termed
as
module
eigenlipid.
Then,
Pearson's
correlation
(r)
calculated
between
eigenlipids
markers.
Lipid
significantly
correlated
considered
be
related
comorbidities.
hypothesis
profiles
constituent
joint
effects
tested
multivariate
variance
(MANOVA).
Among
twelve
studied
modules,
we
identified
one
105
(r
0.24,
p-value
2
×
10−20)
0.16,
10−10).
majority
belonged
glycerolipid
60),
glycerophospholipid
13)
sphingolipid
29)
classes.
also
enriched
ceramides
20),
confirming
their
significance
cardiovascular
outcomes
suggesting
role
top
three
37
statistically
significant
(adjusted
<
0.05)
within
all
triacylglycerols
(TAGs)
–
TAG(18:0/18:0/18:1)
an
adjusted
8.6
10−8,
TAG(18:0/18:1/18:1)
3.7
10−6,
TAG(16:0/18:0/18:1)
8.5
10−6.
This
novel
Alterations
metabolism
and,
more
specifically,
TAG
lipids
may
provide
potential
new
biomarkers
testing
comorbidities,
opening
avenues
emergence
dual-purpose
prevention
measures.
Lipids in Health and Disease,
Journal Year:
2017,
Volume and Issue:
16(1)
Published: Dec. 1, 2017
Atherosclerotic
cardiovascular
disease
(ASCVD)
is
the
leading
cause
of
death
and
it
has
been
confirmed
that
increased
low
density
lipoprotein
cholesterol
(LDL-C)
an
independent
risk
factor
for
atherosclerosis.
Recently,
increasing
evidence
showed
hypertriglyceridemia
associated
with
incremental
ASCVD
risk.
But
proatherogenic
mechanism
triglyceride
(TG)
remains
unclear.
Therefore,
this
article
focuses
on
clinical
studies
related
to
hypertriglyceridemia,
in
order
provide
reference
prevention
treatment
ASCVD.
Biological reviews/Biological reviews of the Cambridge Philosophical Society,
Journal Year:
2022,
Volume and Issue:
97(5), P. 1844 - 1867
Published: May 15, 2022
Atherosclerosis,
characterized
by
lipid-rich
plaques
in
the
arterial
wall,
is
an
age-related
disorder
and
a
leading
cause
of
mortality
worldwide.
However,
specific
mechanisms
remain
complex.
Recently,
emerging
evidence
has
demonstrated
that
senescence
various
types
cells,
such
as
endothelial
cells
(ECs),
vascular
smooth
muscle
(VSMCs),
macrophages,
progenitor
(EPCs),
adipose-derived
mesenchymal
stem
(AMSCs)
contributes
to
atherosclerosis.
Cellular
atherosclerosis
share
causative
stimuli,
which
dyslipidemia
attracted
much
attention.
Dyslipidemia,
mainly
referred
elevated
plasma
levels
atherogenic
lipids
or
lipoproteins,
functional
impairment
anti-atherogenic
plays
pivotal
role
both
cellular
In
this
review,
we
summarize
current
for
dyslipidemia-induced
during
atherosclerosis,
with
focus
on
low-density
lipoprotein
(LDL)
its
modifications,
hydrolysate
triglyceride-rich
lipoproteins
(TRLs),
high-density
(HDL),
respectively.
Furthermore,
describe
underlying
linking
Finally,
discuss
senescence-related
therapeutic
strategies
special
attention
given
anti-atherosclerotic
effects
promising
geroprotectors
well
anti-senescence
lipid-lowering
drugs.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: March 8, 2022
Background
Systemic
immune
inflammation
is
a
key
mediator
in
the
progression
of
coronary
artery
disease
(CAD),
concerning
various
metabolic
and
lipid
changes.
In
this
study,
relationship
between
inflammatory
index
profile
patients
with
CAD
was
investigated
to
provide
deep
insights
into
disturbances
related
inflammation.
Methods
Widely
targeted
plasma
metabolomic
lipidomic
profiling
performed
1,234
CAD.
Laboratory
circulating
markers
were
mainly
used
define
general
systemic
low-grade
states.
Multivariable-adjusted
linear
regression
adopted
assess
associations
860
metabolites
7
markers.
Least
absolute
shrinkage
selection
operator
(LASSO)
logistic-based
classifiers
multivariable
logistic
applied
identify
biomarkers
states
develop
models
for
discriminating
an
advanced
state.
Results
Multiple
species
linearly
associated
seven
[false
discovery
rate
(FDR)
<0.05].
LASSO
multivariable-adjusted
analysis
identified
significant
45
immune-inflammation
index,
46
neutrophil–lymphocyte
ratio
states,
32
score,
26
high-sensitivity
C-reactive
protein
(
P
<
0.05).
Glycerophospholipid
metabolism
arginine
proline
determined
as
altered
pathways
Predictive
based
solely
on
metabolite
combinations
showed
feasibility
(area
under
curve:
0.81
0.88)
four
parameters
that
represent
successfully
validated
using
validation
cohort.
The
inflammation-associated
metabolite,
namely,
β-pseudouridine,
carotid
arteriosclerosis
indicators
Conclusions
This
study
provides
further
information
profiles
represented
by
These
potential
pathological
changes
during
may
aid
development
therapeutic
targets.
Annual Review of Nutrition,
Journal Year:
2015,
Volume and Issue:
35(1), P. 265 - 294
Published: May 14, 2015
Dietary
lipids
are
efficiently
absorbed
by
the
small
intestine,
incorporated
into
triglyceride-rich
lipoproteins
(chylomicrons),
and
transported
in
circulation
to
various
tissues.
Intestinal
lipid
absorption
mobilization
chylomicron
synthesis
secretion
highly
regulated
processes.
Elevated
production
rate
contributes
dyslipidemia
seen
common
metabolic
disorders
such
as
insulin-resistant
states
type
2
diabetes
likely
increases
risk
for
atherosclerosis
these
conditions.
An
in-depth
understanding
of
regulation
may
provide
leads
development
drugs
that
could
be
therapeutic
utility
prevention
atherosclerosis.
Chylomicron
is
subject
factors,
including
diet,
body
weight,
genetic
variants,
hormones,
nutraceuticals,
medications,
emerging
interventions
bariatric
surgical
procedures.
In
this
review
we
discuss
production,
mechanisms
underlie
dysregulation,
potential
avenues
future
research.